[The thrombocytic link in hemostasis and the immunity system of patients with HIV infection]. 1995

A M Poliakova, and A V Kravchenko, and O S Astrina, and L V Serebrovskaia, and V V Khabarova, and O G Iurin, and V V Pokrovskiĭ, and V V Maleev

To find out possible relationships between disturbances in the thrombocytic element of hemostasis and in the immune system (the count of lymphocytes CD4, the concentration of IgG, the content of circulating immune complexes), 18 adult patients with HIV infection were examined, and in 8 of them thrombocytopenia was diagnosed. 10 patients without thrombocytopenia formed the control group. The study revealed that with the development of thrombocytopenia in patients with HIV infection the aggregation capacity of their blood platelets decreased, which correlated (p < 0.01) with a decrease in the count of lymphocytes CD4; this was indicative of the progress of immunodeficiency.

UI MeSH Term Description Entries
D007107 Immune System The body's defense mechanism against foreign organisms or substances and deviant native cells. It includes the humoral immune response and the cell-mediated response and consists of a complex of interrelated cellular, molecular, and genetic components. Immune Systems,System, Immune,Systems, Immune
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D006487 Hemostasis The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION. Hemostases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

A M Poliakova, and A V Kravchenko, and O S Astrina, and L V Serebrovskaia, and V V Khabarova, and O G Iurin, and V V Pokrovskiĭ, and V V Maleev
January 1984, Sovetskaia meditsina,
A M Poliakova, and A V Kravchenko, and O S Astrina, and L V Serebrovskaia, and V V Khabarova, and O G Iurin, and V V Pokrovskiĭ, and V V Maleev
January 1995, Terapevticheskii arkhiv,
A M Poliakova, and A V Kravchenko, and O S Astrina, and L V Serebrovskaia, and V V Khabarova, and O G Iurin, and V V Pokrovskiĭ, and V V Maleev
January 1993, Kardiologiia,
A M Poliakova, and A V Kravchenko, and O S Astrina, and L V Serebrovskaia, and V V Khabarova, and O G Iurin, and V V Pokrovskiĭ, and V V Maleev
January 1985, Vestnik Akademii meditsinskikh nauk SSSR,
A M Poliakova, and A V Kravchenko, and O S Astrina, and L V Serebrovskaia, and V V Khabarova, and O G Iurin, and V V Pokrovskiĭ, and V V Maleev
January 1989, Terapevticheskii arkhiv,
A M Poliakova, and A V Kravchenko, and O S Astrina, and L V Serebrovskaia, and V V Khabarova, and O G Iurin, and V V Pokrovskiĭ, and V V Maleev
January 1995, Klinicheskaia meditsina,
A M Poliakova, and A V Kravchenko, and O S Astrina, and L V Serebrovskaia, and V V Khabarova, and O G Iurin, and V V Pokrovskiĭ, and V V Maleev
January 1996, Anesteziologiia i reanimatologiia,
A M Poliakova, and A V Kravchenko, and O S Astrina, and L V Serebrovskaia, and V V Khabarova, and O G Iurin, and V V Pokrovskiĭ, and V V Maleev
July 1991, Vrachebnoe delo,
A M Poliakova, and A V Kravchenko, and O S Astrina, and L V Serebrovskaia, and V V Khabarova, and O G Iurin, and V V Pokrovskiĭ, and V V Maleev
July 1978, Pediatriia,
A M Poliakova, and A V Kravchenko, and O S Astrina, and L V Serebrovskaia, and V V Khabarova, and O G Iurin, and V V Pokrovskiĭ, and V V Maleev
January 1997, Likars'ka sprava,
Copied contents to your clipboard!